No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
DAWN Day One Biopharmaceuticals
- 12.790
- +0.330+2.65%
Close Dec 20 16:00 ET
- 12.790
- 0.0000.00%
Post 16:20 ET
1.29BMarket Cap-13.19P/E (TTM)
13.000High12.110Low2.28MVolume12.370Open12.460Pre Close29.03MTurnover3.28%Turnover RatioLossP/E (Static)100.85MShares18.07052wk High2.32P/B887.84MFloat Cap11.94052wk Low--Dividend TTM69.42MShs Float28.699Historical High--Div YieldTTM7.14%Amplitude5.440Historical Low12.744Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Day One Biopharm Is Maintained at Buy by Jones Trading
Day One Biopharmaceutical Analyst Ratings
Day One Biopharmaceuticals (DAWN) Posts Stellar Q3 but With Extreme Concentration Risk
JonesTrading Maintains Day One Biopharmaceuticals(DAWN.US) With Buy Rating, Cuts Target Price to $34
CBTN Partners With Day One to Drive New Therapies for Pediatric Brain Tumors
Piper Sandler Maintains Day One Biopharmaceuticals(DAWN.US) With Buy Rating, Maintains Target Price $40
Heat List
US
Overall
Symbol
Price
% Chg
No Data